DCM
MRTX
DAFNA Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-89,387
| Closed | -$5.25M | – | 86 |
|
|
2023
Q4 | $5.25M | Sell |
89,387
-3,500
| -4% | -$206K | 1.26% | 26 |
|
|
2023
Q3 | $4.05M | Sell |
92,887
-1,813
| -2% | -$79K | 1.26% | 26 |
|
|
2023
Q2 | $3.42M | Buy |
94,700
+21,100
| +29% | +$762K | 0.94% | 33 |
|
|
2023
Q1 | $2.74M | Hold |
73,600
| – | – | 0.82% | 35 |
|
|
2022
Q4 | $3.33M | Buy |
73,600
+2,000
| +3% | +$90.6K | 0.94% | 32 |
|
|
2022
Q3 | $5M | Sell |
71,600
-8,000
| -10% | -$559K | 1.35% | 25 |
|
|
2022
Q2 | $5.34M | Buy |
79,600
+36,900
| +86% | +$2.48M | 1.46% | 22 |
|
|
2022
Q1 | $3.51M | Buy |
+42,700
| New | +$3.51M | 0.91% | 31 |
|
|
2020
Q3 | – | Sell |
-21,893
| Closed | -$2.5M | – | 93 |
|
|
2020
Q2 | $2.5M | Sell |
21,893
-20,209
| -48% | -$2.31M | 0.72% | 38 |
|
|
2020
Q1 | $3.24M | Buy |
+42,102
| New | +$3.24M | 1.35% | 23 |
|